Overall rank by patents
#20,671
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
480 Biomedical Inc.
USPTO PatentsView assignee record - 13 granted patents across 7 technology areas, active 2015–2020. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
13
Total patents granted
7
CPC technology areas
18.9
Avg claims per patent
-92%
5-year filing velocity
The verdict
480 holds 13 US patents across 7 technology areas, rank #20,671 of 50,000 tracked assignees.
- #20,671
- of 50,000 US assignees by volume
- Top 68%
- by Innovation Score (29.8/100)
- 18.9
- avg claims per patent
- -92%
- filing velocity, last 5 yrs
Portfolio overview
480 Biomedical Inc. has been granted 13 US utility patents between 2015 and 2020, placing 480 Biomedical Inc. at rank #20,671 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.9 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a US Corporation, 480 Biomedical Inc. is one of the more focused assignees in the PatentsView dataset. By volume, 480 sits between 1281329 Alberta Ltd. (13 patents, rank #20,667) and Aadigen, Llc (13 patents, rank #20,675) - the closest US assignees by grant volume. The composite Innovation Score of 29.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 1 grants, compared with 12 in the 2015–2019 window, a -92% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. 480 Biomedical Inc.'s 18.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark 480 Biomedical Inc. against peers pursuing similar technology classes.
Who files at 480's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- 1281329 Alberta
1281329 Alberta Ltd.
13 patents
- 1lss
1Lss, Inc
13 patents
- 206 Ortho
206 ORTHO, INC.
13 patents
- 32health
32Health Inc.
13 patents
- 7D Surgical ULC
7D SURGICAL ULC
13 patents
- @PAY IP Holdings
@PAY IP HOLDINGS LLC
13 patents
- A&P Technology
A&P TECHNOLOGY, INC.
13 patents
- Aadigen
AADIGEN, LLC
13 patents
- 480 Biomedical ◀
480 Biomedical Inc.
13 patents
What this shows 480 holds 13 patents at rank #20,671, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near 480
By rank, the assignees closest to #20,671 in granted patent volume.
Leaders in A61F (Filters Implantable INTO Blood Vessels)
Other assignees with the most granted patents in 480's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- Depuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- COOK Medical Technologies Llc 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien Lp 528 in class
480's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
30 Top 68% higher than 32% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 23.1% |
| 2016 | 2 | 15.4% |
| 2017 | 1 | 7.7% |
| 2018 | 2 | 15.4% |
| 2019 | 4 | 30.8% |
| 2020 | 1 | 7.7% |
Which technologies does 480 Biomedical Inc. patent most?
Top 7 of 7 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Declining
Frequently Asked Questions
How many patents does 480 Biomedical Inc. hold?
480 Biomedical Inc. holds 13 US granted patents filed between 2015 and 2020, spanning 7 technology areas.
What is 480 Biomedical Inc.'s Innovation Score?
480 Biomedical Inc. has an Innovation Score of 29.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does 480 Biomedical Inc. focus on?
480 Biomedical Inc.'s top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 13 patents. The company has filed patents in 7 CPC subclasses total.
Is 480 Biomedical Inc.'s patent filing rate increasing or decreasing?
480 Biomedical Inc.'s recent filing velocity is -92% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for 480 Biomedical Inc.'s patents?
480 Biomedical Inc.'s patents average 18.9 claims each. This falls within the standard range, providing solid legal coverage.
How is the 480 Biomedical Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
480's 13 grants land it in the top 68% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - 480 ranks #20,671 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61F - see who else leads that technology area. A61F leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.